← Back to Search

Imaging Device

Evaluation of C-Scan Capsule in Identifying Subjects With Elevated Risk of Colon Polyps

N/A
Waitlist Available
Research Sponsored by Check-Cap Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-10 days post colonoscopy
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new method where people swallow a small capsule that takes pictures inside their body to find colon polyps. It targets people who are at high risk for these polyps. The capsule's pictures are checked for accuracy. Capsule colonoscopy is a minimally invasive imaging method that has been shown to be feasible, accurate, and safe in detecting colonic polyps.

Eligible Conditions
  • Healthy Subjects

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-10 days post colonoscopy
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-10 days post colonoscopy for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Demonstrate the accuracy of the C-Scan system in identifying subjects with colon polyps comparing to optical colonoscopy (OC).
Secondary study objectives
Demonstrate subjects' satisfaction and usability with the C-Scan System
Colonoscopy
Demonstrate the safety of the C-Scan System
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: C-Scan SystemExperimental Treatment1 Intervention
All study participants will undergo the C-Scan System procedure, followed by a standard of care optical colonoscopy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
C-Scan System
2018
N/A
~290

Find a Location

Who is running the clinical trial?

Check-Cap Ltd.Lead Sponsor
8 Previous Clinical Trials
1,442 Total Patients Enrolled
~6 spots leftby Dec 2025